• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHI3L1 在肝脏疾病的病理生理学和诊断中的作用。

CHI3L1 in the pathophysiology and diagnosis of liver diseases.

机构信息

Department of Hepatology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo 315010, China; Medical School of Ningbo University, Ningbo 315211, China.

Medical School of Ningbo University, Ningbo 315211, China.

出版信息

Biomed Pharmacother. 2020 Nov;131:110680. doi: 10.1016/j.biopha.2020.110680. Epub 2020 Aug 28.

DOI:10.1016/j.biopha.2020.110680
PMID:32861071
Abstract

Chitinase 3-like protein 1(CHI3L1) participates in physiological and pathophysiological process, such as cell survival, cell proliferation, tissue remodeling, angiogenesis, etc. Some studies demonstrated that CHI3L1 is liver-enriched and has better application value in staging liver fibrosis than platelet ratio index(APRI) and fibrosis-4 index(FIB-4) and that CHI3L1 can be used in monitoring the prognosis of hepatocellular carcinoma (HCC). In this review, we summarized the pathophysiological role and the diagnostic value of CHI3L1 in liver fibrosis in different background and HCC.

摘要

几丁质酶 3 样蛋白 1(CHI3L1)参与细胞存活、细胞增殖、组织重塑、血管生成等生理和病理生理过程。一些研究表明,CHI3L1 是肝脏丰富的,在分期肝纤维化方面比血小板比值指数(APRI)和纤维化 4 指数(FIB-4)具有更好的应用价值,并且 CHI3L1 可用于监测肝细胞癌(HCC)的预后。在这篇综述中,我们总结了 CHI3L1 在不同背景下肝纤维化和 HCC 中的病理生理作用和诊断价值。

相似文献

1
CHI3L1 in the pathophysiology and diagnosis of liver diseases.CHI3L1 在肝脏疾病的病理生理学和诊断中的作用。
Biomed Pharmacother. 2020 Nov;131:110680. doi: 10.1016/j.biopha.2020.110680. Epub 2020 Aug 28.
2
The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases.血清几丁质酶3样蛋白1在乙型肝炎相关慢性肝病中的临床意义
J Clin Lab Anal. 2020 May;34(5):e23200. doi: 10.1002/jcla.23200. Epub 2020 Jan 8.
3
Diagnostic and prognostic value of serum Chitinase 3-like protein 1 in hepatocellular carcinoma.血清几丁质酶 3 样蛋白 1 对肝细胞癌的诊断和预后价值。
J Clin Lab Anal. 2022 Feb;36(2):e24234. doi: 10.1002/jcla.24234. Epub 2022 Jan 16.
4
[Diagnostic value of serum chitinase-3-like protein 1 in chronic liver disease of significant fibrosis and cirrhosis].血清几丁质酶-3样蛋白1在显著肝纤维化和肝硬化慢性肝病中的诊断价值
Zhonghua Gan Zang Bing Za Zhi. 2018 May 20;26(5):337-341. doi: 10.3760/cma.j.issn.1007-3418.2018.05.005.
5
Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.基于 4 项因素的纤维化指数 (FIB-4) 可预测慢性丙型肝炎病毒 (HCV) 患者的肝硬化和肝细胞癌。
Med Sci Monit. 2019 Sep 27;25:7243-7250. doi: 10.12659/MSM.918784.
6
Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis.几丁质酶 3 样蛋白 1 是一种促纤维化因子,在衰老的肝脏和肝硬化患者中过度表达。
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17). doi: 10.1073/pnas.2019633118.
7
New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.新的多蛋白模式可区分慢性丙型肝炎血清样本中的肝纤维化阶段和肝细胞癌。
World J Gastroenterol. 2006 Dec 21;12(47):7604-12. doi: 10.3748/wjg.v12.i47.7604.
8
Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.台湾地区几丁质酶3样1单核苷酸多态性与肝细胞癌的相关性
Int J Med Sci. 2017 Feb 7;14(2):136-142. doi: 10.7150/ijms.17754. eCollection 2017.
9
Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography.几丁质酶-3样蛋白1、天冬氨酸转氨酶与血小板比值指数及纤维化-4指数与剪切波弹性成像的比较
Eur J Gastroenterol Hepatol. 2019 Mar;31(3):357-362. doi: 10.1097/MEG.0000000000001291.
10
A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma.一种新型无创模型,用于诊断肝癌患者的肝纤维化分期。
Sci Rep. 2018 Aug 30;8(1):13074. doi: 10.1038/s41598-018-31351-3.

引用本文的文献

1
Establishment of a YKL-40 time-resolved Immunoassay and Application in Diabetic Kidney Disease.YKL-40时间分辨免疫分析方法的建立及其在糖尿病肾病中的应用
J Fluoresc. 2025 Aug 18. doi: 10.1007/s10895-025-04507-4.
2
Association of serum chitinase-3-like protein 1 with sarcopenia in patients with type 2 diabetes mellitus.2型糖尿病患者血清几丁质酶-3样蛋白1与肌肉减少症的关联
J Endocrinol Invest. 2025 Jul 8. doi: 10.1007/s40618-025-02649-7.
3
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease.
与脂肪肝疾病患者相比,健康个体的肝脏转录组受标准化餐食的调控存在差异。
PLoS One. 2025 Jun 9;20(6):e0307345. doi: 10.1371/journal.pone.0307345. eCollection 2025.
4
Development of a chitosanase 3-like protein 1 assay kit and study of its application in patients with hepatocellular carcinoma.壳聚糖酶3样蛋白1检测试剂盒的研制及其在肝细胞癌患者中的应用研究
BMC Biotechnol. 2025 May 12;25(1):35. doi: 10.1186/s12896-025-00970-w.
5
Chitinase 3-like protein 1 deficiency ameliorates drug-induced acute liver injury by inhibition of neutrophil recruitment through lipocalin-2.几丁质酶3样蛋白1缺乏通过脂钙蛋白-2抑制中性粒细胞募集来改善药物诱导的急性肝损伤。
Front Pharmacol. 2025 Mar 24;16:1548832. doi: 10.3389/fphar.2025.1548832. eCollection 2025.
6
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement.肝脏衰老的生物标志物框架:衰老生物标志物联盟共识声明。
Life Med. 2024 Jan 30;3(1):lnae004. doi: 10.1093/lifemedi/lnae004. eCollection 2024 Feb.
7
Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: A Comprehensive Review.几丁质酶-3样蛋白1在人体多个系统中的炎症效应及调节机制:综述
Int J Mol Sci. 2024 Dec 15;25(24):13437. doi: 10.3390/ijms252413437.
8
Serum CHI3L1 Levels Predict Overall Survival of Hepatocellular Carcinoma Patients after Hepatectomy.血清几丁质酶3样蛋白1水平可预测肝癌患者肝切除术后的总生存期。
J Cancer. 2024 Oct 14;15(19):6315-6325. doi: 10.7150/jca.100791. eCollection 2024.
9
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis.壳三糖酶蛋白 1 是合并肌内脂肪变性的肝细胞癌患者的预后生物标志物。
BMC Cancer. 2024 Aug 23;24(1):1042. doi: 10.1186/s12885-024-12808-3.
10
Non-Invasive Monitoring of the Impact of Low-Level Viremia on Liver Fibrosis in Treated Chronic Hepatitis B Patients.低水平病毒血症对慢性乙型肝炎治疗患者肝纤维化影响的无创监测
Infect Drug Resist. 2024 Jul 3;17:2751-2758. doi: 10.2147/IDR.S463843. eCollection 2024.